Cytokinetics
CYTK
#2423
Rank
S$9.57 B
Marketcap
S$68.74
Share price
-3.35%
Change (1 day)
-15.07%
Change (1 year)

EPS for Cytokinetics (CYTK)

EPS in 2023 (TTM): S-$7.77

According to Cytokinetics 's latest financial reports the company's current EPS (TTM) is S-$9.24. In 2022 the company made an earnings per share (EPS) of S-$5.44 a decrease over its 2021 EPS that were of S-$3.62.

EPS history for Cytokinetics from 2003 to 2023

Annual EPS

Year EPS Change
2023 (TTM)S-$7.7742.85%
2022S-$5.4450.18%
2021S-$3.6240.8%
2020S-$2.57-4.74%
2019S-$2.708.21%
2018S-$2.50-24.12%
2017S-$3.29-776.32%
2016S$0.49-139.18%
2015S-$1.24125.58%
2014S-$0.55-67.67%
2013S-$1.70-44.58%
2012S-$3.07-44.95%
2011S-$5.58-6.84%
2010S-$5.99-290.24%
2009S$3.15-135.96%
2008S-$8.7610.68%
2007S-$7.91-33.97%
2006S-$11.985.41%
2005S-$11.37-60.64%
2004S-$28.88-77.21%
2003S-$126.75

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Amgen
AMGN
S$20.77-324.65%๐Ÿ‡บ๐Ÿ‡ธ USA
Trevena
TRVN
S-$44.48 381.16%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$12.82-238.64%๐Ÿ‡บ๐Ÿ‡ธ USA
Acorda Therapeutics
ACOR
S-$64.41 596.81%๐Ÿ‡บ๐Ÿ‡ธ USA
Array Technologies
ARRY
S-$1.25-86.43%๐Ÿ‡บ๐Ÿ‡ธ USA